NYSE:ABTMedical Equipment
How Abbott Baby Formula Verdict and Rising Litigation Risk May Reshape Abbott Laboratories' (ABT) Investment Profile
In late March 2026, a Chicago jury ordered Abbott Laboratories to pay US$53 million in compensatory damages to families alleging the company failed to adequately warn that its cow’s milk-based formula for premature infants could cause necrotizing enterocolitis, a potentially deadly bowel disease.
This verdict, with punitive damages still to be determined, raises fresh questions about Abbott’s legal exposure, brand perception in infant nutrition, and the potential long-term impact on its...